Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 131 - 140 of 1,147
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al
as 1:2023cv00582
Plaintiff: Vertex Pharmaceuticals Incorporated
Defendant: Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Sun Pharmaceutical Industries Limited
as 1:2023cv00666
Plaintiff: Vertex Pharmaceuticals Incorporated
Defendant: Sun Pharmaceutical Industries Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2023cv00581
Plaintiff: Vertex Pharmaceuticals Incorporated
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2023cv00665
Plaintiff: Bayer Pharma AG, Janssen Pharmaceuticals, Inc. and Bayer AG
Defendant: Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Lupin Limited et al
as 1:2023cv00750
Plaintiff: AbbVie Inc.
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd et al v. Apotex Inc. et al
as 1:2023cv00734
Plaintiff: Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CMP Development, LLC v. Hetero USA Inc. et al
as 1:2023cv00747
Plaintiff: CMP Development, LLC
Defendant: Hetero USA Inc., Hetero Labs Limited Unit - III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00715
Plaintiff: Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant: Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00716
Plaintiff: Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Defendant: Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?